Occupational Therapists in Warren, ME Accepting Medicare
7 Occupational Therapists found. Showing 1 - 7
 Mrs. Kathleen Bertelsen Cartwright, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 117 Eastern Rd, Warren, ME 04864 Phone: 207-273-2001 |
Blakelee Jordan, MOT, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3208 Camden Rd, Warren, ME 04864 Phone: 207-593-8165 |
Gina Longbottom, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3208 Camden Rd, Warren, ME 04864 Phone: 207-273-8100 Fax: 207-273-8103 |
Marissa Eldridge Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3208 Camden Rd, Warren, ME 04864 Phone: 207-273-8100 |
Audrey Frances Averill Blagdon, MS, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 191 Camden Rd, Warren, ME 04864 Phone: 207-273-8100 |
Ms. Courtney Elizabeth Machado, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 191 Camden Rd, Warren, ME 04864 Phone: 207-273-8100 |
Marissa Erin Kelley, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3208 Camden Road, Warren, ME 04864 Phone: 207-594-5076 Fax: 207-594-7339 |
News Archive
InDevR, Applied Microarrays partner to offer complete system solution for multiplexed assays
InDevR Inc., a Boulder-based biotechnology company, and Applied Microarrays, Inc., a Tempe-based contract microarray manufacturer have partnered to deliver a complete system solution for multiplexed assays. The platform includes custom protein and DNA arrays, reagents and protocols, a fluorescent scanner for slides or plates (Vidia) and a colorimetric scanner for lower throughput applications (ampliPHOX).
DaVita Kidney Care releases list of top 10 U.S. travel destinations for dialysis patients
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today released a list of the top 10 U.S. travel destinations for dialysis patients.
Drugs delay disease progression for women with hormone-receptor-positive metastatic breast cancer
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
Threshold commences combination Phase 1/2 trial of TH-302 and sunitinib for RCC, GIST and PNET
Threshold Pharmaceuticals, Inc., today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET).
› Verified 7 days ago